Ticker Details
4D Molecular Therapeutics, Inc.
IPO Date:	December 11, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$502.35M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.60 | 3.57%
Avg Daily Range (30 D):	$0.27 | 2.95%
Avg Daily Range (90 D):	$0.32 | 3.45%

Institutional Daily Volume
Avg Daily Volume:	.45M
Avg Daily Volume (30 D):	.65M
Avg Daily Volume (90 D):	.7M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	71
Avg Trade Size (Sh.) (90 D):	72

Institutional Trades
Total Institutional Trades:	1,187
Avg Institutional Trade:	$1.79M
Avg Institutional Trade (30 D):	$1.37M
Avg Institutional Trade (90 D):	$1.32M
Avg Institutional Trade Volume:	.11M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.75M
Avg Closing Trade (30 D):	$1.12M
Avg Closing Trade (90 D):	$1.28M
Avg Closing Volume:	105.14K

News

Feb 19, 2026 @ 1:00 PM 4DMT to Participate in Upcoming Investor Conferenc... Source: Na

Nov 17, 2025 @ 11:00 AM 4DMT Appoints Kristian Humer as Chief Financial Of... Source: 4D Molecular Therapeutics

Oct 31, 2025 @ 3:02 AM 4DMT Announces Exclusive License Agreement with Ot... Source: 4D Molecular Therapeutics

Sep 11, 2025 @ 10:00 AM GenVivo Strengthens Oncology Leadership with Appoi... Source: Genvivo, Inc.

Aug 11, 2025 @ 12:16 PM 4dMT Revenue Jumps 200 Percent in Q2 Source: Jesterai

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.42	$.43	$-2.42
Diluted EPS	$-2.42	$.43	$-2.42
Revenue	$85.21M	$85.09M	$85.21M
Gross Profit
Net Income / Loss	$-140.11M	$19.4M	$-140.11M
Operating Income / Loss	$-159.55M	$14.72M	$-159.55M
Cost of Revenue
Net Cash Flow	$-89.1M	$11.69M	$-89.1M
PE Ratio